Land: Australien
Språk: engelska
Källa: Department of Health (Therapeutic Goods Administration)
bimatoprost, Quantity: 0.3 mg/mL
Arrotex Pharmaceuticals Pty Ltd
Eye Drops, solution
Excipient Ingredients: hydrochloric acid; sodium hydroxide; dibasic sodium phosphate heptahydrate; citric acid monohydrate; water for injections; sodium chloride; benzalkonium chloride
Ophthalmic
1x3.0mL
(S4) Prescription Only Medicine
Bimatoprost is indicated for the reduction of elevated intraocular pressure, or open angle glaucoma, as first line therapy or monotherapy or as adjunctive therapy to topical beta-blockers.
Visual Identification: Clear, colourless aqueous solution; Container Type: Bottle; Container Material: PP; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius
Registered
2018-07-10